Business UpdateJul 10, 2026, 09:01 AM
Palisade Bio Management to Attend Leerink Partners Forum
AI Summary
Palisade Bio, Inc. announced that its CEO, JD Finley, and President & Chief Medical Officer, Dr. Mitchell Jones, will participate in the Leerink Partners Therapeutics Forum on July 14-15, 2026. They will engage in one-on-one meetings with institutional investors to discuss the company's clinical development strategy, recent progress with PALI-2108, and upcoming milestones for its inflammatory bowel disease programs.
Key Highlights
- Palisade Bio management will participate in the Leerink Partners Therapeutics Forum.
- The forum will take place on July 14-15, 2026, in Boston, Massachusetts.
- CEO JD Finley and President & CMO Dr. Mitchell Jones will attend.
- Management will hold one-on-one meetings with institutional investors.
- Discussions will cover clinical development strategy and PALI-2108 progress.
- Upcoming milestones for inflammatory bowel disease programs will also be discussed.
Price Impact
More from PALI